| 2023年中报 | 2022年年报 | 2022年中报 | |
|---|---|---|---|
| 营业收入(元) | |||
| 医药中间体(元) | 16,420,404.44 | 52,105,327.70 | 32,339,697.46 |
| 原料药(元) | 224,310,688.01 | 450,303,584.62 | 233,875,261.31 |
| 制剂(元) | 409,763,221.04 | 860,813,981.04 | 389,830,209.33 |
| 其他业务(元) | - | 9,011,024.56 | 2,820,670.75 |
| 营业成本(元) | |||
| 医药中间体(元) | 17,799,775.97 | 46,461,935.08 | 28,935,737.90 |
| 原料药(元) | 174,004,686.33 | 312,201,793.67 | 156,568,861.97 |
| 制剂(元) | 122,742,099.26 | 235,255,083.76 | 100,842,402.77 |
| 其他业务(元) | - | 6,870,813.98 | 103,146.92 |
| 毛利(元) | |||
| 医药中间体(元) | -1,379,371.53 | 5,643,392.62 | 3,403,959.56 |
| 原料药(元) | 50,306,001.68 | 138,101,790.95 | 77,306,399.34 |
| 制剂(元) | 287,021,121.78 | 625,558,897.28 | 288,987,806.56 |
| 其他业务(元) | - | 2,140,210.58 | 2,717,523.83 |
| 毛利率(%) | |||
| 医药中间体(%) | -8.40 | 10.83 | 10.53 |
| 原料药(%) | 22.43 | 30.67 | 33.05 |
| 制剂(%) | 70.05 | 72.67 | 74.13 |
| 其他业务(%) | - | 23.75 | 96.34 |
| 收入构成(%) | |||
| 医药中间体(%) | 2.52 | 3.80 | 4.91 |
| 原料药(%) | 34.48 | 32.82 | 35.50 |
| 制剂(%) | 62.99 | 62.73 | 59.17 |
| 其他业务(%) | - | 0.66 | 0.43 |
| 毛利构成(%) | |||
| 医药中间体(%) | -0.41 | 0.73 | 0.91 |
| 原料药(%) | 14.97 | 17.90 | 20.76 |
| 制剂(%) | 85.44 | 81.09 | 77.60 |
| 其他业务(%) | - | 0.28 | 0.73 |